Serum Institute of India said on Thursday it would manufacture an experimental tuberculosis vaccine under an agreement with the Gates Medical Research Institute, in what is likely to be the first new TB shot in more than 100 years if approved.
The novel vaccine candidate, M72/AS01E, has been in development for two decades and is currently in a late-stage clinical trial.
